RE: Mcap13 Oct 2025 08:00
Jdbanzi, I’m afraid your numbers as presented are quite a way out. Firstly, Tyseley and German plants have a 330tpa nameplate capacity, roughly a third of the size of the US plants. Their NPV’s will also be completely different as we have already spent the capex. Add to that that we as Mkango effectively own 80% of Tyseley and 72% of German plant vs c. 40% of the US plants.
I’ve done NPV calcs for Tyseley and German plants previously, which I don’t have to hand as am on the phone. But it was in the region of $172m NPV for Tyseley and $156m for Germany based on current 330tpa planned throughput. One US plant is worth about $260m NPV to Mkango ($650m current NPV quoted by Julian x our share of ~40%).
Adding those three together plus MKAR at $400m we get to roughly $988m, so just under a billion. Of course you can then add the other two announced US projects at up to $260m NPV a pop, possible expansion of Tyseley and German plant, South Korean, Canadian and Japanese plants to reach the billions. The strong argument is also that our share of the MKAR valuation will be much higher than $400m on listing and that the NPV for Hypromag US plants will be greatly enhanced by low cost EXIM financing, grants, tax breaks and higher prices/a price floor.